-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Chondrokin in Osteoarthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Chondrokin in Osteoarthritis Drug Details:Chondrokin is under development for the treatment of osteoarthritis. The therapy comprises...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Oral Cavity (Mouth) Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Oral Cavity (Mouth) Cancer Drug Details: BMX-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EP-547 in Hepatitis C
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Hepatitis C Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due to...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FPI-2265 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. FPI-2265 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details: FPI-2265 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elebsiran in Hepatitis B
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Elebsiran in Hepatitis BDrug Details: Elebsiran (VIR-2218) is under development for the treatment of hepatitis B...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Paltusotine Hydrochloride in Carcinoid Syndrome (Malignant Carcinoid Syndrome)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Paltusotine Hydrochloride in Carcinoid Syndrome (Malignant Carcinoid Syndrome) Drug Details: Paltusotine hydrochloride (CRN-00808) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Neuroendocrine Tumors
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Neuroendocrine Tumors Drug Details: PAC-1 (also known as VO-100) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Elebsiran in Hepatitis B
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Elebsiran in Hepatitis B Drug Details: Elebsiran (VIR-2218) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Rheumatoid Arthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Rheumatoid Arthritis Drug Details: Lu-AG22515 is under development for the treatment of neuromyelitis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OMS-405 in Smoking Cessation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OMS-405 in Smoking Cessation Drug Details: OMS-405 (OMS-403) is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.